Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02520778
Brief Title: Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

First Submitted : August 10, 2015
First Submitted that Met QC Criteria : August 10, 2015
First Posted : August 13, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 11, 2021
Last Update Posted : February 12, 2021